Briumvi (ublituximab-xiiy) is one of the newer FDA-approved infused disease-modifying therapies (DMTs) for relapsing forms of MS. It was approved in December 2022, so it's relatively new compared to some other infused options.
Here's what to know about the infusion schedule:
- The first two infusions are given two weeks Show Full Answer
Briumvi (ublituximab-xiiy) is one of the newer FDA-approved infused disease-modifying therapies (DMTs) for relapsing forms of MS. It was approved in December 2022, so it's relatively new compared to some other infused options.
Here's what to know about the infusion schedule:
- The first two infusions are given two weeks apart
- After that, infusions are every 24 weeks (about every 6 months)
This less frequent schedule is something many people find appealing compared to monthly infusions. Like all infused DMTs, Briumvi does carry some potential side effects to be aware of:
- Infusion reactions — these are common with most infused DMTs, but clinics monitor you closely during treatment
- Upper respiratory tract infections
- Other infections
Before starting, your neurologist will likely run a series of lab tests to make sure the medication is safe for you. These can include blood tests, liver function checks, and screenings for certain viruses. A few tips that MyMSTeam members swear by for infusion day:
- Hydrate well the day before and day of your infusion — one study showed this helped reduce infusion reactions by 60%
- Ask about premedication like antihistamines or acetaminophen to reduce reactions
- Plan to rest afterward — fatigue is common post-infusion
- Bring entertainment — a book, tablet, or headphones can make the time fly
It's always a great idea to talk openly with your neurology team about any concerns before your first infusion. You've got this! 💪
May 30
Join
Your Privacy Choices
